Major Depression

Published on 03/03/2015 by admin

Filed under Neurology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1588 times

29 Major Depression

This vignette provides a classic picture of severe depression (Fig. 29-1). This is the most common serious psychiatric disorder; practicing physicians encounter it very frequently in many different guises. Depression is a very significant illness; it ranks second only to cardiovascular disease in overall morbidity and economic loss. Up to 20% of individuals within a general population will have at least one major depressive episode during their lifetime. Women have a higher incidence of depression between menarche and menopause, with an especially high risk postpartum. When depression affects men, the long-term risk of suicide is more common.

Depression usually begins in adolescence or early adulthood. It is a chronic illness with a propensity for recurrence. One common clinical pattern, called “double depression,” is characterized by repeated episodes of depression (Fig. 29-2) with eventual remission to a milder “dysthymic” state (Chapter 28). Familial clustering is apparent, although specific genes have not been identified. Depression beginning after age 60 years is probably a different disorder. It is less often associated with a significant family history but is associated with cerebrovascular disease and periventricular white matter abnormalities.

Clinical Presentation

Major depression predominantly presents with a 2-plus-week history of a sad or anxious mood; impaired energy and concentration; anhedonia (loss of pleasure from normally enjoyable experiences); insomnia, often with early morning wakening; loss of appetite; feelings of worthlessness or guilt; and recurrent thoughts of death or suicide. The presence of predominant diurnal mood fluctuation—feeling worse in the morning—is almost pathognomonic of depression. It is not uncommon to find disturbed sleep architecture with shortened rapid eye movement latency. Many patients have subtle endocrine disturbances, especially hypercortisolism that is not clinically apparent.

One of the major medical concerns vis-à-vis any severely depressed patient is that suicide ideation and very definite attempts of the same are a common occurrence (Fig. 29-3). Although overt suicide attempts are notoriously difficult to predict, physicians must maintain a heightened sense of alertness to assessing suicide risk. One must always stand by to offer help and intervention per se when necessary, especially with the patient having significant suicidal risk factors. These include being a male, intense anxiety or agitation, social isolation, advanced age, history of previous suicide attempts, psychosis, and known alcohol abuse.

Certain medical conditions may provoke or mimic major depression. These most commonly include hypothyroidism, alcohol abuse, or need for corticosteroid therapy such as in the patient with myasthenia gravis. Depressed alcoholics and drug abusers are very unlikely to maintain a recovery from depression unless they maintain their sobriety.

Psychotic depression may develop in those individuals who are the most severely depressed at presentation. This is typically characterized by delusions that are “affect consonant,” for example, delusions of poverty, moral depravity, or life-threatening illness. Bowel delusions are the most common of the various physical complaints that the depressed patient may express their inappropriate concern. The recognition of psychotic thinking in the depressed patient has very definite therapeutic consequences. This is particularly important because this subgroup of patients with depression fails to respond to standard antidepressant medications. There are two primary therapeutic options for psychotically depressed patients: (1) electroconvulsive therapy or (2) a combination of antidepressant and antipsychotic medication.

A primary bipolar disorder may underlie or be masked per se in at least 10% of individuals presenting with what appears on first pass to be unipolar depression. One single episode of mania will establish the bipolar diagnosis. A heightened level of suspicion for the presence of underlying bipolar disorder is necessary for anyone raised in a family with history of bipolar disorder, having experienced a childhood onset of depressive illness, or a poor therapeutic response. Similarly, if the patient experiences a sudden response to initiation of antidepressant medication, that is, “switching,” rather than following the usual delayed therapeutic response, a bipolar disorder requires further consideration. Efforts should be made to limit the exposure of patients with known or suspected bipolar disorder to the usual antidepressant medications (Chapter 30).

Treatment

Treatment of major depression combines specific pharmacologic medications with psychotherapy; the two are synergistic. Psychodynamic theorists divide depression as “anaclitic” or “introjective.” Anaclitic patients feel ineffective and reliant on others for support. They get depressed when they feel abandoned, and respond well to supportive psychotherapy. Introjective patients set excessively high demands for themselves, are harshly self-critical, and feel guilty and worthless when they do not meet their own expectations. Both groups have characteristically distorted thinking even when well; they are overly passive, feel powerless, and evaluate problems in all-or-none terms. Cognitive therapies that target these patterns are the best-validated psychotherapeutic interventions.

The most useful information source for medical management of depression is the ongoing STAR*D study. This is a large multicenter, NIMH-funded trial dedicated to medication switching and augmentation strategies. Most antidepressant medications are equally effective, producing significant improvement in 60–70% of patients and full remission in 30–40%.

Selective serotonin reuptake inhibitors (SSRIs) are the preferred pharmacologic agents for initial treatment as they have milder side effects. Furthermore, the SSRIs are less lethal when taken as an overdose in comparison with the earlier developed tricyclic antidepressants. However, there is some controversy present as to whether SSRIs are as effective as tricyclics in severely depressed patients.

Although monoamine oxidase inhibitors (MAOIs) are often very effective for control of depression, unfortunately these pharmacologic agents have a unique potential for precipitating a hypertensive crisis and tachycardia. This occurs when norepinephrine is displaced from storage vesicles if patients are exposed to tyramine-containing foods. Tyramine is an amine that is typically produced by decarboxylation of the amino acid tyrosine during fermentation of various food products. These include Chianti and vermouth wines, aged cheeses, certain fruits such as eggplant, avocados, figs, grapes and prunes, as well as very high quantities of chocolate. A similar response may occur when MAOIs are given to patients already taking various other medications, particularly meperidine and SSRIs. A transdermal MAOI patch (containing selegiline) is now available. It causes fewer side effects but is very expensive.

Patients who have only a partial response to pharmacologic treatment may sometimes respond to various other therapeutic maneuvers. These include a switch to a different class of antidepressant, addition of a second antidepressant, or of an augmenting agent such as lithium and triiodothyronine (T3). Atypical antipsychotic agents and certain stimulants are also promising.

Additionally, a combination of cognitive behavioral therapy as developed by Beck has proven to be a very useful additive therapeutic modality for some patients.

Electroconvulsive therapy (ECT) is a very important treatment modality for depression. It is indicated for severely depressed individuals who fail medication trials. It has more than a 90% response rate in well-selected populations. ECT is also the first-line treatment for psychotic depression, intense suicidal ideation, and the otherwise medically ill patients. Public misunderstanding may have led to its being underutilized. Unilateral electrode placement has significantly diminished the occurrence of post-ECT confusion. Today the concomitant employment of modern anesthetic agents has significantly decreased the frequency of other complications such as spinal compression fractures.

It is most important to recognize that depression is usually a chronic illness. Therefore a maintenance and prophylactic treatment protocol should be considered at time of diagnosis for each patient. Active treatment for first episodes should last at least six months, preferably one year. After three episodes, indefinite lifelong prophylaxis with full-dose antidepressant medication is indicated.